A

Quantifying how HIV-1 envelope sequence features impact vaccine efficacy in the HVTN 705/HPX2008 randomised trial in southern African women

EBioMedicine, vol. 131, pp. 106459

Abstract

BACKGROUND: A heterologous Ad26.Mos4.HIV and clade C gp140 vaccine regimen did not show overall significant efficacy against HIV-1 acquisition [point estimate 14.1%; 95% confidence interval (CI), -22.0 to 39.5] in the HVTN 705/HPX2008 trial in southern African women. We examined whether and how vaccine efficacy (VE) against HIV-1 diagnosis over 7-24 months post-first dose varied by HIV-1 Envelope (Env) amino acid sequence features. METHODS: HIV-1 viral sequences were generated by PacBio SMRT-UMI sequencing from the first RNA-positive sample of participants who acquired HIV-1. Env amino acid sequence features were prespecified for analyses based on 1) being hypothesised to impact VE; and 2) having sufficient variability. Sieve analyses assessed VE by a single representative sequence and by viral population composition. FINDINGS: The majority of Env features showed no evidence of differential VE, with only two signals having familywise error rate (FWER) P-values <0.10. In single-sequence analyses, VE declined with increasing physicochemical-weighted Hamming distance from the C97ZA vaccine insert in clade C broadly neutralising antibody resistance-associated signature positions (FWER P = 0.08). Sequence-predicted Env structural features showed no significant vaccine vs. placebo differences in structural divergence from the C97ZA vaccine-insert Env sequence. In multi-sequence analyses (median 121 sequences/individual), VE was higher against viral populations with ≥99% vs. <99% L832 prevalence (VE = 91.7%; 95% CI, 67.4-97.9 vs. VE = -7.0%; 95% CI, -55.5 to 26.4) (unadjusted P = 0.0002 for differential VE, FWER P = 0.023). INTERPRETATION: Despite extensive prespecified and exploratory analyses including Env features supported by prior studies to potentially impact VE, there was only limited, weak evidence that Env sequence features modified VE in HVTN 705. Although previous work suggested a protective role of IgG3 binding to V1V2 in a small subgroup of vaccine recipients, a V1V2 sieve signal was absent. FUNDING: National Institutes of Health and Johnson & Johnson.

Authors 36

  1. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA. Electronic address: mjuraska@fredhutch.org

  2. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  3. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  4. University of Washington · Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA; Department of Biostatistics, University of Washington, Seattle, WA, 98195, USA

  5. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  6. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  7. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  8. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  9. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  10. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  11. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  12. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  13. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  14. University of Washington

    Affiliation as printed

    Department of Microbiology, University of Washington School of Medicine, Seattle, WA, 98195, USA

  15. University of Washington

    Affiliation as printed

    Department of Microbiology, University of Washington School of Medicine, Seattle, WA, 98195, USA

  16. University of Washington

    Affiliation as printed

    Department of Microbiology, University of Washington School of Medicine, Seattle, WA, 98195, USA

  17. University of Washington

    Affiliation as printed

    Department of Microbiology, University of Washington School of Medicine, Seattle, WA, 98195, USA

  18. National Health Laboratory Service · University of Cape Town · Wellcome Centre for Infectious Diseases Research in Africa · Institute of Infectious Disease and Molecular Medicine

    Affiliation as printed

    Institute of Infectious Disease and Molecular Medicine and CIDRI-Africa Wellcome Centre, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town, 7701, South Africa

  19. National Health Laboratory Service · University of Cape Town · Wellcome Centre for Infectious Diseases Research in Africa · Institute of Infectious Disease and Molecular Medicine

    Affiliation as printed

    Institute of Infectious Disease and Molecular Medicine and CIDRI-Africa Wellcome Centre, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town, 7701, South Africa

  20. National Health Laboratory Service · University of Cape Town · Wellcome Centre for Infectious Diseases Research in Africa · Institute of Infectious Disease and Molecular Medicine

    Affiliation as printed

    Institute of Infectious Disease and Molecular Medicine and CIDRI-Africa Wellcome Centre, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town, 7701, South Africa

  21. National Health Laboratory Service · University of Cape Town · Wellcome Centre for Infectious Diseases Research in Africa · Institute of Infectious Disease and Molecular Medicine

    Affiliation as printed

    Institute of Infectious Disease and Molecular Medicine and CIDRI-Africa Wellcome Centre, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town, 7701, South Africa

  22. National Health Laboratory Service · University of Cape Town · Wellcome Centre for Infectious Diseases Research in Africa · Institute of Infectious Disease and Molecular Medicine

    Affiliation as printed

    Institute of Infectious Disease and Molecular Medicine and CIDRI-Africa Wellcome Centre, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town, 7701, South Africa

  23. National Health Laboratory Service · University of Cape Town · Wellcome Centre for Infectious Diseases Research in Africa · Institute of Infectious Disease and Molecular Medicine

    Affiliation as printed

    Institute of Infectious Disease and Molecular Medicine and CIDRI-Africa Wellcome Centre, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town, 7701, South Africa

  24. National Health Laboratory Service · University of Cape Town · Wellcome Centre for Infectious Diseases Research in Africa · Institute of Infectious Disease and Molecular Medicine

    Affiliation as printed

    Institute of Infectious Disease and Molecular Medicine and CIDRI-Africa Wellcome Centre, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town, 7701, South Africa

  25. National Health Laboratory Service · University of Cape Town · Wellcome Centre for Infectious Diseases Research in Africa · Institute of Infectious Disease and Molecular Medicine

    Affiliation as printed

    Institute of Infectious Disease and Molecular Medicine and CIDRI-Africa Wellcome Centre, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town, 7701, South Africa

  26. National Institute of Allergy and Infectious Diseases

    Affiliation as printed

    Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, 20852, USA

  27. Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  28. Janssen (Netherlands)

    Affiliation as printed

    Janssen Vaccines & Prevention BV, Leiden, 2333, the Netherlands

  29. San Francisco Department of Public Health

    Affiliation as printed

    San Francisco Department of Public Health, San Francisco, CA, 94102, USA

  30. Janssen Research & Development (United States)

    Affiliation as printed

    Janssen Research & Development, LLC, Titusville, NJ, 08560, USA

  31. University of Washington · Fred Hutch Cancer Center

    Affiliation as printed

    Department of Medicine, University of Washington School of Medicine, Seattle, WA, 98195, USA; Department of Laboratory Medicine, University of Washington School of Medicine, Seattle, WA, 98195, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  32. Aurum Institute

    Affiliation as printed

    The Aurum Institute, Johannesburg, 1609, South Africa

  33. South African Medical Research Council

    Affiliation as printed

    South African Medical Research Council, Cape Town, 7505, South Africa

  34. University of Washington · Fred Hutch Cancer Center

    Affiliation as printed

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA; Department of Biostatistics, University of Washington, Seattle, WA, 98195, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA

  35. National Health Laboratory Service · University of Cape Town · Wellcome Centre for Infectious Diseases Research in Africa · Institute of Infectious Disease and Molecular Medicine

    Affiliation as printed

    Institute of Infectious Disease and Molecular Medicine and CIDRI-Africa Wellcome Centre, Department of Pathology, Faculty of Health Sciences, University of Cape Town and National Health Laboratory Service, Cape Town, 7701, South Africa

  36. University of Washington

    Affiliation as printed

    Department of Microbiology, University of Washington School of Medicine, Seattle, WA, 98195, USA

Cited by 0 stored of 0

No patents citing this paper on Lens.org (checked 2026-10-11).

References 58